These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 12877582)
1. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis. Zhou G; Tsai CW; Liu JO J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582 [TBL] [Abstract][Full Text] [Related]
2. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. Lu J; Chong CR; Hu X; Liu JO J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390 [TBL] [Abstract][Full Text] [Related]
4. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases. Wang J; Lou P; Henkin J J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954 [TBL] [Abstract][Full Text] [Related]
6. Syntheses of fumagillin and ovalicin. Yamaguchi J; Hayashi Y Chemistry; 2010 Apr; 16(13):3884-901. PubMed ID: 20209516 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2. Han CK; Ahn SK; Choi NS; Hong RK; Moon SK; Chun HS; Lee SJ; Kim JW; Hong CI; Kim D; Yoon JH; No KT Bioorg Med Chem Lett; 2000 Jan; 10(1):39-43. PubMed ID: 10636239 [TBL] [Abstract][Full Text] [Related]
8. Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2. Arico-Muendel CC; Benjamin DR; Caiazzo TM; Centrella PA; Contonio BD; Cook CM; Doyle EG; Hannig G; Labenski MT; Searle LL; Lind K; Morgan BA; Olson G; Paradise CL; Self C; Skinner SR; Sluboski B; Svendsen JL; Thompson CD; Westlin W; White KF J Med Chem; 2009 Dec; 52(24):8047-56. PubMed ID: 19929003 [TBL] [Abstract][Full Text] [Related]
9. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel fumagillin and ovalicin analogues. Mazitschek R; Huwe A; Giannis A Org Biomol Chem; 2005 Jun; 3(11):2150-4. PubMed ID: 15917904 [TBL] [Abstract][Full Text] [Related]
11. Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model. Chun E; Han CK; Yoon JH; Sim TB; Kim YK; Lee KY Int J Cancer; 2005 Mar; 114(1):124-30. PubMed ID: 15523682 [TBL] [Abstract][Full Text] [Related]
12. MetAP-2 inhibitors based on the fumagillin structure. Side-chain modification and ring-substituted analogues. Rodeschini V; Boiteau JG; Van de Weghe P; Tarnus C; Eustache J J Org Chem; 2004 Jan; 69(2):357-73. PubMed ID: 14725448 [TBL] [Abstract][Full Text] [Related]
13. 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo. Kallander LS; Lu Q; Chen W; Tomaszek T; Yang G; Tew D; Meek TD; Hofmann GA; Schulz-Pritchard CK; Smith WW; Janson CA; Ryan MD; Zhang GF; Johanson KO; Kirkpatrick RB; Ho TF; Fisher PW; Mattern MR; Johnson RK; Hansbury MJ; Winkler JD; Ward KW; Veber DF; Thompson SK J Med Chem; 2005 Sep; 48(18):5644-7. PubMed ID: 16134930 [TBL] [Abstract][Full Text] [Related]
14. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010 [TBL] [Abstract][Full Text] [Related]
15. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides. Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784 [TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2). Garrabrant T; Tuman RW; Ludovici D; Tominovich R; Simoneaux RL; Galemmo RA; Johnson DL Angiogenesis; 2004; 7(2):91-6. PubMed ID: 15516829 [TBL] [Abstract][Full Text] [Related]
18. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. Endo H; Takenaga K; Kanno T; Satoh H; Mori S J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292 [TBL] [Abstract][Full Text] [Related]
19. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930 [TBL] [Abstract][Full Text] [Related]
20. 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2. Sheppard GS; Wang J; Kawai M; BaMaung NY; Craig RA; Erickson SA; Lynch L; Patel J; Yang F; Searle XB; Lou P; Park C; Kim KH; Henkin J; Lesniewski R Bioorg Med Chem Lett; 2004 Feb; 14(4):865-8. PubMed ID: 15012983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]